The list is “an unusual mix of words that are tied to activities that this administration has been at war with — like equity — but also words that they purport to be in favor of doing ...

Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...

Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Swiss pharma giant Roche has announced the launch of the Roche Genentech Innovation Center Boston, USA, at Harvard’s Enterprise Research Campus in Allston which will further strengthen the ...

Known as Susvimo and approved by the FDA in 2021, the implant delivers the drug to the eye gradually and needs refilling only every six months. Installing the device requires hospital surgery ...

The products are expected to be available in June 2025. Osenvelt is indicated to prevent skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid ...

The FDA signed off Monday on the use of Roche’s thrombolytic drug TNKase to treat acute ischemic stroke in adult patients. According to Roche subsidiary Genentech, which announced the label expansion ...

Finally, DeWilde explored future developments in anti-VEGF treatment, including biosimilars, implantable devices like Susvimo, and potential new delivery methods such as eye drops. He emphasized ...

In January and February, the FDA approved the NovoLog biosimilar MeriLog and issued an alert for diabetes-related smartphone device alerts. In January and February, the Food and Drug Administration ...